Fotios Sampaziotis

Fotios Sampaziotis is a UK Research and Innovation (UKRI) Future Leaders Fellow and a group leader at the University of Cambridge and an honorary consultant hepatologist in Addenbrooke’s hospital. He obtained his medical degree from the University of Athens and completed his hepatology clinical training in Cambridge. In parallel, he secured an MRC Clinical Research Training Fellowship towards a PhD degree in the Cambridge Stem Cell Institute and continued his post-doctoral research as an NIHR Clinical Lectureship in Hepatology with Prof Ludovic Vallier in Cambridge.

Fotios’ research combines bioengineering, cell therapies and human organs perfused ex-vivo to develop new disruptive regenerative medicine therapies. His work in regenerative medicine has received international recognition with multiple awards including the Science and Sartorius Award for Regenerative Medicine, the British Transplantation Society Medawar Medal and the UEG Rising Star award (2022). He serves as an active member of multiple international consortia and governing boards, including the EASL Regenerative Hepatology consortium. He is the vice-chair of the European Cell Therapy and Organ Regeneration Section (ECTORS) governing board, a visiting Professor in the university of Oslo and theme lead for liver research in the NHS Blood and Transplant Research Unit on Organ Donation. To translate his research into clinical products, Fotis co-founded Bilitech ltd, a startup biotechnology company listed as finalist in the Nature and Merck spinoff prize and is currently acting as CEO of the company.